Maintenance of Remission with Tofacitinib in Patients With Ulcerative Colitis: Subpopulation Analysis from an Open-Label, Long-Term Extension Study

被引：1
|
作者：
Jean-Frederic, Colombel [1 ]
Walter, Reinisch [2 ]
Mark, Osterman T. [3 ]
Andrew, Thorpe J. [4 ]
Chudy, Nduaka, I [4 ]
Zhang Haiying [4 ]
Nervin, Lawendy [4 ]
Gary, Friedman S. [4 ]
Su Chinyu [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA
[2] Med Univ Vienna, Dept Internal Med 3, Vienna, Austria
[3] Penn Presbyterian Med Ctr, Div Gastroenterol, Philadelphia, PA USA
[4] Pfizer Inc, Collegeville, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
10.14309/00000434-201802001-00015
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-015
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [1] Maintenance of Remission With Tofacitinib in Patients With Ulcerative Colitis: Subpopulation Analysis From an Open-Label, Long-Term Extension Study
    Colombel, Jean-Frederic
    Reinisch, Walter
    Osterman, Mark T.
    Thorpe, Andrew J.
    Nduaka, Chudy I.
    Zhang, Haiying
    Lawendy, Nervin
    Friedman, Gary S.
    Su, Chinyu
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S389 - S390
  • [2] Maintenance of remission with tofacitinib in patients with ulcerative colitis: Updated results of a subpopulation analysis from an open-label, long-term extension study, OCTAVE Open
    Colombel, J. F.
    Osterman, M. T.
    Ibanez, P.
    Thorpe, A. J.
    Zhang, H.
    Lawendy, N.
    Su, C.
    Reinisch, W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S098 - S099
  • [3] MAINTENANCE OF REMISSION WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS: FINAL RESULTS OF A SUBPOPULATION ANALYSIS FROM AN OPEN-LABEL, LONG-TERM EXTENSION STUDY, OCTAVE OPEN
    Colombel, Jean Frederic
    Osterman, Mark T.
    Ibanez, Patricio
    Vermeire, Severine
    Irving, Peter M.
    Gardiner, Sean M.
    Connelly, Susan B.
    Mundayat, Rajiv
    Lawendy, Nervin
    Su, Chinyu
    Reinisch, Walter
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S125 - S126
  • [4] MAINTENANCE OF REMISSION WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS: UPDATED RESULTS OF A SUBPOPULATION ANALYSIS FROM AN OPEN-LABEL, LONG-TERM EXTENSION STUDY, OCTAVE OPEN
    Colombel, Jean Frederic
    Osterman, Mark T.
    Ibanez, Patricio
    Thorpe, Andrew J.
    Zhang, Haiying
    Lawendy, Nervin
    Su, Chinyu
    Reinisch, Walter
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1198 - S1199
  • [5] Persistence of Tofacitinib Treatment in Patients With Ulcerative Colitis Who Entered the Open-Label, Long-Term Extension Study, OCTAVE OPEN in Remission or With a Clinical Response
    Panaccione, Remo
    Abreu, Maria T.
    Lazariciu, Irina
    Mundayat, Rajiv
    Lawendy, Nervin
    Salese, Leonardo
    Woolcott, John C.
    Sands, Bruce E.
    Chaparro, Maria
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S351 - S351
  • [6] TOFACITINIB, AN ORAL JAK INHIBITOR, IN THE TREATMENT OF ULCERATIVE COLITIS: OPEN-LABEL, LONG-TERM EXTENSION STUDY
    Bloom, Stuart
    Lichtenstein, Gary R.
    Loftus, Edward V.
    Lawendy, Nervin
    Friedman, Gary S.
    Zhang, Haiying
    Wang, Wenjin
    Thorpe, Andrew J.
    Nduaka, Chudy I.
    Su, Chinyu
    [J]. GUT, 2018, 67 : A62 - A63
  • [7] Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Ulcerative Colitis: Open-Label, Long-term Extension Study
    Lichtenstein, Gary R.
    Loftus, Edward V., Jr.
    Bloom, Stuart
    Lawendy, Nervin
    Friedman, Gary S.
    Zhang, Haiying
    Wang, Wenjin
    Thorpe, Andrew J.
    Nduaka, Chudy I.
    Su, Chinyu
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S395 - S395
  • [8] Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: Data from the open-label, long-term extension study, OCTAVE open
    Panaccione, Remo
    Abreu, Maria T.
    Lazariciu, Irina
    Mundayat, Rajiv
    Lawendy, Nervin
    Salese, Leonardo
    Woolcott, John C.
    Sands, Bruce E.
    Chaparro, Maria
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (12) : 1534 - 1544
  • [9] Persistence of Tofacitinib Treatment in Patients With Ulcerative Colitis Who Entered the Open-Label, Long-Term Extension Study, OCTAVE OPEN Without a Clinical Response
    Panaccione, Remo
    Abreu, Maria T.
    Lazariciu, Irina
    Mundayat, Rajiv
    Lawendy, Nervin
    Salese, Leonardo
    Woolcott, John C.
    Sands, Bruce E.
    Chaparro, Maria
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S351 - S352
  • [10] Ulcerative Colitis: Tofacitinib as Long-Term Maintenance Therapy after Remission
    Franke, Katharina
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (03): : 284 - 285
12345